Reichmann, Heinz

Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke

Ehrenreich, H., Weissenborn, K., Prange, H., Schneider, D., Weimar, C., Wartenberg, K., Schellinger, P. D., Bohn, M., Becker, H., Wegrzyn, M., et al. (2009) · Stroke

Erythropoietin and Anemia TreatmentAcute Ischemic Stroke Management

Cited by 605

Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors

Klingelhoefer, L., & Reichmann, H. (2015) · Nature Reviews Neurology

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 598

Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage

Kuramatsu, J. B., Gerner, S. T., Schellinger, P. D., Glahn, J., Endres, M., Sobesky, J., Flechsenhar, J., Neugebauer, H., Jüttler, E., Grau, A., et al. (2015) · JAMA

Intracerebral and Subarachnoid Hemorrhage ResearchAcute Ischemic Stroke Management

Cited by 568

Clinical Criteria for the Diagnosis of Parkinson’s Disease

Reichmann, H. (2010) · Neurodegenerative Diseases

Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders

Cited by 145

Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis

Kern, S., Schrempf, W., Schneider, H., Schultheiß, T., Reichmann, H., & Ziemssen, T. (2009) · Multiple Sclerosis Journal

Multiple Sclerosis Research StudiesCancer survivorship and care

Cited by 65

Oxidative Stress to Dopaminergic Neurons as Models of Parkinson's Disease

GILLE, G., HUNG, S., REICHMANN, H., & RAUSCH, W. (2004) · Annals of the New York Academy of Sciences

Parkinson's Disease Mechanisms and TreatmentsCoenzyme Q10 studies and effects

Cited by 53